Entity Details

Primary name S12A5_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9H2X9
EntryNameS12A5_HUMAN
FullNameSolute carrier family 12 member 5
TaxID9606
Evidenceevidence at protein level
Length1139
SequenceStatuscomplete
DateCreated2002-12-13
DateModified2021-06-02

Ontological Relatives

GenesSLC12A5

GO terms

Show/Hide Table
GOName
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0006811 ion transport
GO:0006873 cellular ion homeostasis
GO:0006884 cell volume homeostasis
GO:0006971 hypotonic response
GO:0007268 chemical synaptic transmission
GO:0007612 learning
GO:0015108 chloride transmembrane transporter activity
GO:0015379 potassium:chloride symporter activity
GO:0016021 integral component of membrane
GO:0019901 protein kinase binding
GO:0030644 cellular chloride ion homeostasis
GO:0035264 multicellular organism growth
GO:0040040 thermosensory behavior
GO:0042493 response to drug
GO:0043005 neuron projection
GO:0043025 neuronal cell body
GO:0045202 synapse
GO:0055064 chloride ion homeostasis
GO:0055075 potassium ion homeostasis
GO:0060996 dendritic spine development
GO:0071944 cell periphery
GO:1902476 chloride transmembrane transport
GO:1990573 potassium ion import across plasma membrane

Subcellular Location

Show/Hide Table
Subcellular Location
Membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR000076 K/Cl co-transporterFamilyFamily
IPR004841 Amino acid permease/ SLC12A domainDomainDomain
IPR004842 SLC12A transporter familyFamilyFamily
IPR018491 SLC12A transporter, C-terminalDomainDomain
IPR030358 K/Cl co-transporter 2FamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
616645 OMIMDevelopmental and epileptic encephalopathy 34 (DEE34)A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE34 is characterized by onset of refractory migrating focal seizures in infancy. Affected children show developmental regression and are severely impaired globally. The disease is caused by variants affecting the gene represented in this entry.
616685 OMIMEpilepsy, idiopathic generalized 14 (EIG14)An autosomal dominant form of idiopathic generalized epilepsy, a disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. Seizure types include juvenile myoclonic seizures, absence seizures, and generalized tonic-clonic seizures. Disease susceptibility is associated with variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00761 Potassium chlorideDrugbanksmall molecule
DB00887 BumetanideDrugbanksmall molecule

Interactions

2 interactions

InteractorPartnerSourcesPublicationsLink
S12A5_HUMANCCR4_HUMANBioGRID, MINT28298427 details
S12A5_HUMANPAR2_HUMANBioGRID, MINT28298427 details